Some answers, more controversy, from UKPDS
- 1 September 1998
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 352 (9131) , 832-833
- https://doi.org/10.1016/s0140-6736(98)22937-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?The Lancet, 1997
- Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive DiseaseDiabetes, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Inferences and Implications: Do results from the Diabetes Control and Complications Trial apply in NIDDM?Diabetes Care, 1995
- UK prospective diabetes study (UKPDS)Diabetologia, 1991